Loading…
Acetylharpagide Protects Mice from Staphylococcus Aureus -Induced Acute Lung Injury by Inhibiting NF-κB Signaling Pathway
( )-induced acute lung injury (ALI) is a serious disease that has a high risk of death among infants and teenagers. Acetylharpagide, a natural compound of Thunb. (family Labiatae), has been found to have anti-tumor, anti-inflammatory and anti-viral effects. This study investigates the therapeutic ef...
Saved in:
Published in: | Molecules (Basel, Switzerland) Switzerland), 2020-11, Vol.25 (23), p.5523 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | (
)-induced acute lung injury (ALI) is a serious disease that has a high risk of death among infants and teenagers. Acetylharpagide, a natural compound of
Thunb. (family Labiatae), has been found to have anti-tumor, anti-inflammatory and anti-viral effects. This study investigates the therapeutic effects of acetylharpagide on
-induced ALI in mice. Here, we found that acetylharpagide alleviated
-induced lung pathological morphology damage, protected the pulmonary blood-gas barrier and improved the survival of
-infected mice. Furthermore,
-induced myeloperoxidase (MPO) activity of lung homogenate and pro-inflammatory factors in bronchoalveolar lavage (BAL) fluid were suppressed by acetylharpagide. Mechanically, acetylharpagide inhibited the interaction between polyubiquitinated receptor interacting protein 1 (RIP1) and NF-κB essential modulator (NEMO), thereby suppressing NF-κB activity. In summary, these results show that acetylharpagide protects mice from
-induced ALI by suppressing the NF-κB signaling pathway. Acetylharpagide is expected to become a potential treatment for
-induced ALI. |
---|---|
ISSN: | 1420-3049 1420-3049 |
DOI: | 10.3390/molecules25235523 |